NIH Announces New Program to Develop Therapeutics for Rare and Neglected Diseases – 1
Narrator: This is NIH Health Matters. More than 25 million Americans suffer from rare diseases.
Dr. Guttmacher: And millions of people who have diseases for which there’s no effective therapy today.
Narrator: Dr. Alan Guttmacher is the acting director of the National Human Genome Research Institute.
Dr. Guttmacher: What we’re trying to do is develop new effective therapies for both rare diseases and so-called neglected diseases.
Narrator: Neglected diseases are often common in some parts of the world where people cannot afford or otherwise access treatments, if they exist at all. A rare disease is a disease that affects fewer than 200-thousand Americans. Dr. Guttmacher says a new program has been launched to help develop therapies for rare and neglected diseases. For more information, visit www.nih.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.